Dement W C
Sleep Disorders Center, Stanford University, Palo Alto, Calif. 94304.
J Clin Psychiatry. 1992 Dec;53 Suppl:50-6; discussion 57-60.
Insomnia is a highly prevalent problem occurring in about 35% of the adult population. The complaint can be divided into temporary insomnia and persistent insomnia. A 1983 NIMH/OMAR Consensus Development Conference on drugs and insomnia issued guidelines for the use of sleep-promoting medications. There was a consensus that hypnotic medication is indicated for the treatment of temporary insomnia. Temporary insomnia, in response to external circumstances, is real and can have very serious consequences. This paper reviews the proper use of sleeping pills in the primary care setting in the context of current controversy involving benzodiazepines in general and benzodiazepine hypnotics in particular. It is concluded if the physician feels a patient's temporary insomnia warrants symptomatic relief with medication, it is appropriate to prescribe use of the lowest effective dose of a benzodiazepine hypnotic for several nights. Depending on the circumstances, the physician can specify either a short-acting or a long-acting hypnotic. The patient should be firmly instructed to call the clinic or office the next day to report results.
失眠是一个非常普遍的问题,约35%的成年人口都曾出现过。这种主诉可分为暂时性失眠和持续性失眠。1983年美国国立精神卫生研究所/药物滥用和精神健康服务管理局关于药物与失眠的共识发展会议发布了使用促眠药物的指南。会议达成的共识是,催眠药物适用于治疗暂时性失眠。因外部环境引起的暂时性失眠是真实存在的,且可能会产生非常严重的后果。本文在当前关于苯二氮䓬类药物尤其是苯二氮䓬类催眠药的争议背景下,探讨了在初级保健环境中正确使用安眠药的问题。得出的结论是,如果医生认为患者的暂时性失眠需要药物对症缓解,那么开几个晚上最低有效剂量的苯二氮䓬类催眠药是合适的。根据具体情况,医生可以指定使用短效或长效催眠药。应明确告知患者第二天打电话到诊所或办公室报告用药效果。